Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation (Q39070877)

8 September 2017

Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation (English)

1 reference

8 September 2017

0 references

0 references

Haiwen Ni

1

1 reference

8 September 2017

Wanzhou Zhao

2

1 reference

8 September 2017

Xiangtu Kong

3

1 reference

8 September 2017

Haitao Li

4

1 reference

8 September 2017

Jian Ouyang

5

1 reference

8 September 2017

18 October 2013

1 reference

8 September 2017

1 reference

8 September 2017

131

1 reference

8 September 2017

2

1 reference

8 September 2017

102-111

1 reference

8 September 2017

1 reference

Cancer-related inflammation

21 January 2018

1 reference

21 January 2018

1 reference

New insights into the pathophysiology of multiple myeloma

21 January 2018

1 reference

A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications

21 January 2018

1 reference

Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.

21 January 2018

1 reference

Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals

21 January 2018

1 reference

Tumor angiogenesis and molecular targets for therapy

21 January 2018

1 reference

Angiogenesis--a new target for future therapy

21 January 2018

1 reference

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

21 January 2018

Inflammation and cancer

1 reference

Toll-like receptors mediate proliferation and survival of multiple myeloma cells

21 January 2018

1 reference

Stress-sensing toll-like receptor as a driver of angiogenesis

21 January 2018

1 reference

Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors

21 January 2018

1 reference

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer

21 January 2018

1 reference

How Toll-like receptors signal: what we know and what we don't know

21 January 2018

1 reference

21 January 2018

TLR signaling pathways

1 reference

Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer.

21 January 2018

1 reference

Celastrol isolated from Tripterygium regelii induces apoptosis through both caspase-dependent and -independent pathways in human breast cancer cells.

21 January 2018

1 reference

Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor.

21 January 2018

1 reference

Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB

21 January 2018

1 reference

Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice

21 January 2018

1 reference

The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma

21 January 2018

1 reference

Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression

21 January 2018

1 reference

Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells

21 January 2018

1 reference

Apoptosis Induction in HL-60 Cells and Inhibition of Topoisomerase II by Triterpene Celastrol

21 January 2018

1 reference

Antiangiogenic activity of Tripterygium wilfordii and its terpenoids

21 January 2018

1 reference

Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway

21 January 2018

1 reference

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

21 January 2018

1 reference

Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis

21 January 2018

1 reference

Capsaicin inhibits in vitro and in vivo angiogenesis

21 January 2018

1 reference

Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis

21 January 2018

1 reference

Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab

21 January 2018

1 reference

Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1α to promote hepatocellular carcinoma invasiveness

21 January 2018

1 reference

Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells

21 January 2018

1 reference

Endogenous ligands of Toll-like receptors

21 January 2018

1 reference

VEGF receptor signalling - in control of vascular function

21 January 2018

1 reference

Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism

21 January 2018

1 reference

Angiogenesis and chronic inflammation: cause or consequence?

21 January 2018

1 reference

Angiogenesis and remodeling of airway vasculature in chronic inflammation

21 January 2018

1 reference

Lipopolysaccharide from Escherichia coli induces the expression of vascular endothelial growth factor via toll-like receptor 4 in human limbal fibroblasts.

21 January 2018

1 reference

Prophylactic antibiotics for the prevention of early infection in multiple myeloma

21 January 2018

1 reference

Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion

21 January 2018

1 reference

Endogenous toll-like receptor ligands and their biological significance

21 January 2018

1 reference

Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents.

21 January 2018

1 reference

Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin

21 January 2018

1 reference

Toll-like receptors, endogenous ligands, and systemic autoimmune disease.

21 January 2018

1 reference

Up-regulation of vascular endothelial growth factor expression by adenosine through adenosine A2 receptors in the rat tongue treated with endotoxin

21 January 2018

1 reference

Recognition of pathogen-associated molecular patterns by TLR family

21 January 2018

1 reference

The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells

21 January 2018

1 reference

Potential pharmacological control of the NF-κB pathway

21 January 2018

1 reference

Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways

21 January 2018

1 reference

Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells.

21 January 2018

1 reference

Celastrol suppresses breast cancer MCF-7 cell viability via the AMP-activated protein kinase (AMPK)-induced p53-polo like kinase 2 (PLK-2) pathway

21 January 2018

1 reference

Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000354770

1 reference

8 September 2017

1 reference